Difficulty: Medium
Average Score: 90%
Practice
A 64-year-old woman reports to the clinic for her scheduled appointment. She was diagnosed 7 months ago with congestive heart failure. However, the patient refuses to make diet and lifestyle adjustments. She complains her feet are still unable to fit correctly in shoes and her medication has not helped the swelling in her legs and ankles. The doctor decides to increase her level of diuretics after also noting the edematous appearance of her hands. What complication should the doctor be most aware of for this patient?
Correct answer
A
Rationale
In this scenario, the doctor should be most aware of the complication of hypokalemia when increasing the patient's diuretic therapy. Diuretics are commonly used in congestive heart failure to reduce fluid retention; however, they can also lead to potassium loss, resulting in hypokalemia. Hypokalemia can be particularly dangerous in patients with heart failure as it can lead to cardiac arrhythmias and worsen heart function.
Option A, hypokalemia, is the correct answer because diuretics, especially loop diuretics like furosemide, can cause potassium wasting through increased urinary excretion.
Options B, hepatic encephalopathy, and C, hypercalcemia, are not directly related to the use of diuretics in heart failure management. Hepatic encephalopathy is more commonly associated with liver dysfunction, while hypercalcemia is usually linked to parathyroid or bone disorders.
Option D, hyperkalemia, is unlikely to occur when increasing diuretic therapy, as diuretics typically lead to potassium loss rather than retention.
Educational Context: Understanding the potential complications of diuretic therapy is crucial in managing patients with congestive heart failure. Monitoring electrolyte levels, especially potassium, is essential to prevent adverse outcomes like hypokalemia in these patients. Patient education on the importance of dietary potassium intake and regular monitoring of potassium levels can help mitigate the risk of complications associated with diuretic therapy in heart failure.
Option A, hypokalemia, is the correct answer because diuretics, especially loop diuretics like furosemide, can cause potassium wasting through increased urinary excretion.
Options B, hepatic encephalopathy, and C, hypercalcemia, are not directly related to the use of diuretics in heart failure management. Hepatic encephalopathy is more commonly associated with liver dysfunction, while hypercalcemia is usually linked to parathyroid or bone disorders.
Option D, hyperkalemia, is unlikely to occur when increasing diuretic therapy, as diuretics typically lead to potassium loss rather than retention.
Educational Context: Understanding the potential complications of diuretic therapy is crucial in managing patients with congestive heart failure. Monitoring electrolyte levels, especially potassium, is essential to prevent adverse outcomes like hypokalemia in these patients. Patient education on the importance of dietary potassium intake and regular monitoring of potassium levels can help mitigate the risk of complications associated with diuretic therapy in heart failure.